Mangoceuticals (NASDAQ: MGRX) Files PCT Patent for Antiviral Technology
Key Developments Mangoceuticals, Inc. (NASDAQ: MGRX), a leader in health and wellness product innovation, announced the filing of a Patent Cooperation Treaty (PCT) international application to secure global patent protection for its antiviral technology. The filing, completed on February 26, 2026, focuses on the MGX-0024 antiviral animal feed and drinking water additive, aiming to inhibit respiratory or orally acquired virus infections in animals and birds. This initiative demonstrates Mangoceuticals (NASDAQ:…
